Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]

Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]

Background In 2021 we launched the BronchStart study, which collected information on 17,899 presentations in children with serious respiratory tract infections following the release of lockdown restrictions. Our study informed the Joint Committee on Vaccination and Immunisation’s decision to recomme...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark D. Lyttle, Helen Groves, Thomas C. Williams, Simon B. Drysdale, Ian Sinha, Xinxue Liu, Steve Cunningham, Dalia Iskander, Abigail Maxwell-Hodkinson, Shaun O'Hagan, Olivia V. Swann, Chengetai D. Mpamhanga, Damian Roland, Thomas Waterfield, Robin Marlow
Format: Article
Language:English
Published: Wellcome 2024-12-01
Series:Wellcome Open Research
Subjects:
COVID-19
Respiratory Syncytial Virus
Bronchiolitis
Infants
Children
Palivizumab
eng
Online Access:https://wellcomeopenresearch.org/articles/6-120/v4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://wellcomeopenresearch.org/articles/6-120/v4

Similar Items